المصري اليوم
المصري اليوم
Ready to play
Ready to play
The article provides a comprehensive overview of the Egyptian Drug Authority's role in regulating the pharmaceutical market in Egypt, with a focus on the mechanism of mandatory drug pricing to protect patients' rights by ensuring medications are not sold at prices exceeding the official price printed on the packaging. It explains that drug prices are determined after a thorough evaluation of raw materials, quality, stability, and bioequivalence, based on a financial formula that includes production costs, currency exchange rates, and inflation. This aims to prevent price hikes like those seen in 2024. The article also emphasizes that the Authority continuously monitors factories and the supply chain to prevent medication shortages, utilizing a digital tracking system for approximately 12,000 drug items to ensure fair distribution. Additionally, proactive strategies are in place to address potential crises. The article highlights the importance of offering alternatives to medications and avoiding dependence on a single source, while warning against price manipulation. It also provides information to citizens regarding drug availability and guidance on how to handle situations of medication shortages.
Notice: This Is an AI-Generated Summary
Comments (0)